According to CytoDyn latest financial reports the total debt is $997.00K, an increase of 136.26% to 2022. At the end of 2022 company had $422.00K total debt. This figure represents the debts and financial obligations that CytoDyn combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $997.00K | 136.26% |
2022 | $422.00K | -23.55% |
2021 | $552.00K | -93.50% |
2020 | $8.49M | 1768.59% |
2019 | $454.57K | - |